Literature DB >> 23427158

Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Baptiste Jammart1, Maud Michelet, Eve-Isabelle Pécheur, Romain Parent, Birke Bartosch, Fabien Zoulim, David Durantel.   

Abstract

In the plasma samples of hepatitis C virus (HCV)-infected patients, lipoviroparticles (LVPs), defined as (very-) low-density viral particles immunoprecipitated with anti-β-lipoproteins antibodies are observed. This HCV-lipoprotein association has major implications with respect to our understanding of HCV assembly, secretion, and entry. However, cell culture-grown HCV (HCVcc) virions produced in Huh7 cells, which are deficient for very-low-density lipoprotein (VLDL) secretion, are only associated with and dependent on apolipoprotein E (apoE), not apolipoprotein B (apoB), for assembly and infectivity. In contrast to Huh7, HepG2 cells can be stimulated to produce VLDL by both oleic acid treatment and inhibition of the MEK/extracellular signal-regulated kinase (ERK) pathway but are not permissive for persistent HCV replication. Here, we developed a new HCV cell culture model to study the interaction between HCV and lipoproteins, based on engineered HepG2 cells stably replicating a blasticidin-tagged HCV JFH1 strain (JB). Control Huh7.5-JB as well as HepG2-JB cell lines persistently replicated viral RNA and expressed viral proteins with a subcellular colocalization of double-stranded RNA (dsRNA), core, gpE2, and NS5A compatible with virion assembly. The intracellular RNA replication level was increased in HepG2-JB cells upon dimethyl sulfoxide (DMSO) treatment, MEK/ERK inhibition, and NS5A overexpression to a level similar to that observed in Huh7.5-JB cells. Both cell culture systems produced infectious virions, which were surprisingly biophysically and biochemically similar. They floated at similar densities on gradients, contained mainly apoE but not apoB, and were not neutralized by anti-apoB antibodies. This suggests that there is no correlation between the ability of cells to simultaneously replicate HCV as well as secrete VLDL and their capacity to produce LVPs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427158      PMCID: PMC3624324          DOI: 10.1128/JVI.01405-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

Review 1.  Steatosis in chronic hepatitis C: why does it really matter?

Authors:  T Asselah; L Rubbia-Brandt; P Marcellin; F Negro
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

2.  HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; Yasmine S el-Abd; Mahmoud M Bahgat; Hussein A Shoeb; Samar S Youssef; Noha G Bader el-Din; el-Rashdy M Redwan; Maha el-Demellawy; Moataza H Omran; Wael T el-Garf; Said A Goueli
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

4.  MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.

Authors:  Julie Tsai; Wei Qiu; Rita Kohen-Avramoglu; Khosrow Adeli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-12       Impact factor: 8.311

5.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells.

Authors:  Bruno Sainz; Francis V Chisari
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

9.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Authors:  Brett D Lindenbach; Philip Meuleman; Alexander Ploss; Thomas Vanwolleghem; Andrew J Syder; Jane A McKeating; Robert E Lanford; Stephen M Feinstone; Marian E Major; Geert Leroux-Roels; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205

View more
  23 in total

1.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.

Authors:  Ji-Young Lee; Eliana G Acosta; Ina Karen Stoeck; Gang Long; Marie-Sophie Hiet; Birthe Mueller; Oliver T Fackler; Stephanie Kallis; Ralf Bartenschlager
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 3.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes.

Authors:  Sandrine Belouzard; Adeline Danneels; Lucie Fénéant; Karin Séron; Yves Rouillé; Jean Dubuisson
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.

Authors:  Virgínia Gondar; Francisca Molina-Jiménez; Takayuki Hishiki; Luisa García-Buey; George Koutsoudakis; Kunitada Shimotohno; Ignacio Benedicto; Pedro L Majano
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

6.  Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Authors:  Sara Calattini; Floriane Fusil; Jimmy Mancip; Viet Loan Dao Thi; Christelle Granier; Nicolas Gadot; Jean-Yves Scoazec; Mirjam B Zeisel; Thomas F Baumert; Dimitri Lavillette; Marlène Dreux; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

Review 7.  Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Authors:  Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Expert Rev Proteomics       Date:  2017-06-30       Impact factor: 4.250

8.  APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants.

Authors:  Xavier Vanhoye; Alexandre Janin; Amandine Caillaud; Antoine Rimbert; Fabienne Venet; Morgane Gossez; Wieneke Dijk; Oriane Marmontel; Séverine Nony; Charlotte Chatelain; Christine Durand; Pierre Lindenbaum; Jennifer Rieusset; Bertrand Cariou; Philippe Moulin; Mathilde Di Filippo
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

9.  Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Authors:  Francois Helle; Etienne Brochot; Carole Fournier; Véronique Descamps; Laure Izquierdo; Thomas W Hoffmann; Virginie Morel; Yves-Edouard Herpe; Abderrahmane Bengrine; Sandrine Belouzard; Czeslaw Wychowski; Jean Dubuisson; Catherine Francois; Jean-Marc Regimbeau; Sandrine Castelain; Gilles Duverlie
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 10.  Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.

Authors:  Daniel J Felmlee; Mohamed Lamine Hafirassou; Mathieu Lefevre; Thomas F Baumert; Catherine Schuster
Journal:  Viruses       Date:  2013-05-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.